IEX:NYSEIDEX Corporation Analysis
Data as of 2026-09-09 - not real-time
$225.10
Latest Price
3/10Risk
Risk Level: Low
Executive Summary
The moving-average structure behind IDEX Corporation is bullish at $225.10, with short-term averages leading the long-term ones. With RSI at 42.4 the momentum picture is neutral, alongside a bearish MACD signal. The recent range runs from support at $220.98 up to resistance at $242.73.
Multiples put this in fair territory: 32.4 times earnings against the sector's 27.9. Sell-side targets cluster 13.5% above the current quote. Revenue is growing at 6.4% on a 14.5% profit margin. The 1.29% dividend yield looks covered by current payout levels.
The composite risk read is 3/10, putting it in low territory. With 30-day volatility of 20.6%, a beta of 0.69 and a maximum drawdown of 14.5%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 2 out of 10.
Multiples put this in fair territory: 32.4 times earnings against the sector's 27.9. Sell-side targets cluster 13.5% above the current quote. Revenue is growing at 6.4% on a 14.5% profit margin. The 1.29% dividend yield looks covered by current payout levels.
The composite risk read is 3/10, putting it in low territory. With 30-day volatility of 20.6%, a beta of 0.69 and a maximum drawdown of 14.5%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 2 out of 10.
Top Market Events
IDEX Corporation recently reported its second-quarter 2026 results, with sales rising to US$920.Manufacturing company IDEX NYSE:IEX reported in Q2 CY2026, with sales up 6.Manufacturing company IDEX NYSE:IEX reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 206.54
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked above long-term ones
- P/E of 32.4 versus sector average of 27.9
- Trading above the 200-day average of 206.54
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 32.4 versus sector average of 27.9
- Analyst targets imply +13.5% versus the current price
- Dividend yield of 1.29%
Key Metrics & Analysis
Financial Health
Revenue Growth6.40%
Profit Margin14.49%
P/E Ratio32.4
ROE12.96%
ROA6.84%
Debt/Equity47.06
P/B Ratio4.2
Op. Cash Flow$716.7M
Free Cash Flow$555.6M
Industry P/E27.9
Technical Analysis
TrendBullish
RSI42.4
Support$220.98
Resistance$242.73
MA 20$231.63
MA 50$228.71
MA 200$206.54
MACDBearish
VolumeDecreasing
Fear & Greed Index92.04
Valuation
Fair Value$107.60
Target Price$255.57
Upside/Downside13.54%
GradeFair
TypeGrowth
Dividend Yield1.29%
Risk Assessment
Beta0.69
Volatility20.57%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.